BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38000455)

  • 21. Knockdown of FOXA2 enhances the osteogenic differentiation of bone marrow-derived mesenchymal stem cells partly via activation of the ERK signalling pathway.
    Ye C; Chen M; Chen E; Li W; Wang S; Ding Q; Wang C; Zhou C; Tang L; Hou W; Hang K; He R; Pan Z; Zhang W
    Cell Death Dis; 2018 Aug; 9(8):836. PubMed ID: 30082727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17A Inhibits Osteogenic Differentiation of Bone Mesenchymal Stem Cells via Wnt Signaling Pathway.
    Wang Z; Jia Y; Du F; Chen M; Dong X; Chen Y; Huang W
    Med Sci Monit; 2017 Aug; 23():4095-4101. PubMed ID: 28837545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on osteogenesis and angiogenesis of Pluronic F-127 composite gel loaded with transforming growth factor β
    Zhang Y; Wang X; Han S; Zhang X; Wang P; Huo F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Nov; 35(11):1472-1478. PubMed ID: 34779176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. αCGRP Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Through ERK1/2 and p38 MAPK Signaling Pathways.
    Jiang Y; Xin N; Xiong Y; Guo Y; Yuan Y; Zhang Q; Gong P
    Cell Transplant; 2022; 31():9636897221107636. PubMed ID: 35758252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-182 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Smad1.
    Zheng HB; Wu M; Zhang G; Chen KL
    J Biol Regul Homeost Agents; 2021; 35(2):505-516. PubMed ID: 33691396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taohong Siwu Decoction enhances human bone marrow mesenchymal stem cells proliferation, migration and osteogenic differentiation via VEGF-FAK signaling in vitro.
    Lu X; Li J; Zhou B; Lu X; Li W; Ouyang J
    J Ethnopharmacol; 2023 May; 307():116203. PubMed ID: 36682599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferation and Differentiation Potential of Bone Marrow-Derived Mesenchymal Stem Cells From Children With Polydactyly and Adults With Basal Joint Arthritis.
    Yeh SH; Yu JH; Chou PH; Wu SH; Liao YT; Huang YC; Chen TM; Wang JP
    Cell Transplant; 2024; 33():9636897231221878. PubMed ID: 38164917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D1 receptor-mediated activation of the ERK signaling pathway is involved in the osteogenic differentiation of bone mesenchymal stem cells.
    Wang CX; Ge XY; Wang MY; Ma T; Zhang Y; Lin Y
    Stem Cell Res Ther; 2020 Jan; 11(1):12. PubMed ID: 31900224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
    Guang LG; Boskey AL; Zhu W
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of FOXA1 enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly via activation of the ERK1/2 signalling pathway.
    Li L; Wang Y; Wang Z; Xue D; Dai C; Gao X; Ma J; Hang K; Pan Z
    Stem Cell Res Ther; 2022 Sep; 13(1):456. PubMed ID: 36064451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Titanium dioxide nanotubes increase purinergic receptor P2Y6 expression and activate its downstream PKCα-ERK1/2 pathway in bone marrow mesenchymal stem cells under osteogenic induction.
    Wang C; Liu Y; Hu X; Shang X; Ma S; Guo H; Ma X; Cai D; Hu Z; Zhao Y; Zhu Y; Cao Z; Yu H; Cheng W
    Acta Biomater; 2023 Feb; 157():670-682. PubMed ID: 36442823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The polypeptide OP3-4 induced osteogenic differentiation of bone marrow mesenchymal stem cells via protein kinase B/glycogen synthase kinase 3β/β-catenin pathway and promoted mandibular defect bone regeneration.
    Li C; Yang P; Kou Y; Zhang D; Li M
    Arch Oral Biol; 2021 Oct; 130():105243. PubMed ID: 34416564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin promotes bone marrow mesenchymal stem cell proliferation and osteogenic differentiation through the H19/miR-625-5p axis to activate the Wnt/β-catenin pathway.
    Bian W; Xiao S; Yang L; Chen J; Deng S
    BMC Complement Med Ther; 2021 Sep; 21(1):243. PubMed ID: 34592982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of FGF-21 on Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells in High Glucose Environment].
    Li X; Chen C; An ZM; Li YJ; Zhang M; He H; Li SQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):649-654. PubMed ID: 28598073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon Monoxide-Releasing Molecule-3 Enhances Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells via miR-195-5p/Wnt3a Pathway.
    Li J; Han Q; Chen H; Liu T; Song J; Hou M; Wei L; Song H
    Drug Des Devel Ther; 2022; 16():2101-2117. PubMed ID: 35812136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galangin inhibits lipopolysaccharide-induced inflammation and stimulates osteogenic differentiation of bone marrow mesenchymal stem cells via regulation of AKT/mTOR signaling.
    Wang X; Xiao X
    Allergol Immunopathol (Madr); 2023; 51(1):133-139. PubMed ID: 36617832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-5 Integrin Mediates Simvastatin-Induced Osteogenesis of Bone Marrow Mesenchymal Stem Cells.
    Shao PL; Wu SC; Lin ZY; Ho ML; Chen CH; Wang CZ
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30682874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annexin A2 Improves the Osteogenic Differentiation of Mesenchymal Stem Cells Exposed to High-Glucose Conditions through Lessening the Senescence.
    Klabklai P; Phetfong J; Tangporncharoen R; Isarankura-Na-Ayudhya C; Tawonsawatruk T; Supokawej A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chrysin Attenuates High Glucose-Induced BMSC Dysfunction via the Activation of the PI3K/AKT/Nrf2 Signaling Pathway.
    Li Y; Wang X
    Drug Des Devel Ther; 2022; 16():165-182. PubMed ID: 35058687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COX-2/PGE
    Wu Y; Liu M; Zhou H; He X; Shi W; Yuan Q; Zuo Y; Li B; Hu Q; Xie Y
    Cytokine; 2023 Jan; 161():156058. PubMed ID: 36209650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.